Momenta Pharmaceuticals, Inc. News Headlines

MNTA 
$10.8
*  
0.19
1.73%
Get MNTA Alerts
*Delayed - data as of Jul. 25, 2014  -  Find a broker to begin trading MNTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Earnings Estimates Moving Higher for Momenta Pharmaceuticals (MNTA): Time to Buy? - Tale of the Tape
6/20/2014 8:42:00 AM - Zacks.com

Pipeline Progress at Momenta - Analyst Blog
6/9/2014 6:35:00 PM - Zacks.com

Momenta's Pancreatic Cancer Drug Necuparanib Gets Orphan Drug Status From FDA
6/5/2014 8:24:00 AM - RTT News

Mylan Gains Slightly on Copaxone News - Analyst Blog
5/16/2014 11:40:00 AM - Zacks.com

Narrower-than-Expected Loss at Momenta - Analyst Blog
5/7/2014 12:10:01 PM - Zacks.com

Momenta Pharmaceuticals Q1 14 Earnings Conference Call At 10:00 AM ET
5/6/2014 9:00:00 AM - RTT News

Momenta Pharmaceuticals Has Value In The Sum Of The Drugs
4/29/2014 10:35:00 AM - Seeking Alpha

Supreme Court Denies Teva's Request - Analyst Blog
4/21/2014 4:35:01 PM - Zacks.com

Healthcare Stocks Continue Rebound; Momenta Pharma Advances After Supreme Court OKs Generic MS Drug Sales
4/21/2014 1:22:11 PM - MT Newswires

Sector Update: Healthcare
4/21/2014 1:05:58 PM - MT Newswires

Mid-Morning Market Update: Markets Rise; Halliburton Posts Q1 Profit
4/21/2014 10:27:40 AM - Benzinga

Momenta Pharmaceuticals Slumps: MNTA Falls 16.9% in Session - Tale of the Tape
4/1/2014 8:55:01 AM - Zacks.com

Pre-Market Earnings Report for February 10, 2014 : L, CNA, HAS, BWP, SOHU, SFUN, MCY, SXT, MNTA, TTI, NSP, CYOU
2/7/2014 5:00:02 PM - NASDAQ.com News

Momenta: Impending Approval Provides Price Support With Excellent Upside Potential
2/1/2014 9:45:00 AM - Seeking Alpha

Momenta Loss Wider than Expected - Analyst Blog
11/7/2013 1:05:21 PM - Zacks.com

Can Teva Survive Its Cash Cow Loss?
10/23/2013 3:05:00 PM - Seeking Alpha

Parker-Hannifin Downgraded to Underperform - Analyst Blog
10/8/2013 9:30:01 AM - Zacks.com

Bulls return to Momenta Pharma
10/2/2013 5:45:18 AM - optionMONSTER

2014 Isn't Looking To Good For Eli Lilly And Company
9/30/2013 3:34:00 PM - Seeking Alpha

TEVA Should Embrace Copaxone Patent Expiration
9/3/2013 4:26:00 PM - Seeking Alpha

Wider-Than-Expected Loss at Momenta - Analyst Blog
8/2/2013 11:07:43 AM - Zacks.com

Favorable Ruling for Momenta - Analyst Blog
7/29/2013 4:30:05 PM - Zacks.com

Will Biogen (BIIB) Beat Earnings Estimates? - Analyst Blog
7/24/2013 1:29:20 PM - Zacks.com

Will Actavis (ACT) Beat Earnings Estimates? - Analyst Blog
7/24/2013 1:20:01 PM - Zacks.com

Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
6/5/2013 5:53:00 AM - Seeking Alpha